Single Cell Analysis Core (Core C)
- Institution
- Emory University, GA
- Principal investigator
- Minsu Kim
- Funding
- $352K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT - CORE C: Single-Cell Analysis Core HR arises from cell-to-cell variation of genotypic and metabolic processes. The goal of the Single-Cell Analysis Core (Core C) is to provide experimentally-validated and yet difficult-to-perform single-cell-level analyses to evaluate the mechanisms and dynamics of HR. Core C will support the single-cell-level studies proposed in all three Projects by providing a centralized platform for culturing bacterial cells under well-controlled antibiotic environments, measuring relevant processes at single-cell resolution, and performing image analysis as well as necessary statistical analysis. Specifically, Core C will i) provide microfluidic continuous culture platform, ii) quantify the copy number variation of resistance genes, and iii) determine metabolic activities of single cells in heteroresistant populations. Core C activities will be conducted by Dr. Minsu Kim's laboratory in the Department of Physics at Emory University, which has extensive expertise in single-cell-level imaging and analysis of gene expression, metabolism, and physiology in bacteria. Dr. Kim was one of the first scientists to apply a single-cell approach to antibiotic research and is considered a leading expert in this area. Dr. Kim and his team will work with the PI of individual projects collaboratively to ensure they can successfully complete their projects in a timely manner.
LOADING MOONBASE SCORE
Questions for Emory University
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Emory University70
Mapping the blood cancer exposome for environmental risk profiles of mature B-cell neoplasms
Douglas Ian Walker · $545K · 2022–2027
- NIH · Emory University69
Learning to Predict Delayed Cerebral Ischemia with Novel Continuous Cerebral Arterial State Index
Xiao Hu · $617K · 2020–2026
- NIH · Emory University66
Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments
Edikan Ogunnaike · $249K · 2022–2028